Whitehawk Therapeutics, Inc. (WHWK) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts WHWK Hot Sheet
Join SI Premium – FREE
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q2 EPS of ($0.20), $0.11 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Arcos Dorados (ARCO) Tops Q2 EPS by 7c
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
